Agrawal Institute Of Medical Sciences Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 25-12-2024
- Paid Up Capital ₹ 2.00 M
as on 25-12-2024
- Company Age 23 Year, 11 Days
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.00 Cr
as on 25-12-2024
- Satisfied Charges ₹ 2.55 Cr
as on 25-12-2024
- Revenue 75.58%
(FY 2022)
- Profit 190.18%
(FY 2022)
- Ebitda 56.01%
(FY 2022)
- Net Worth 8.91%
(FY 2022)
- Total Assets 75.58%
(FY 2022)
About Agrawal Institute Of Medical Sciences
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 2.00 M.
The company currently has active open charges totaling ₹2.00 Cr. The company has closed loans amounting to ₹2.55 Cr, as per Ministry of Corporate Affairs (MCA) records.
Simmi Agrawal, Sajan Agrawal, and Siddharth Agrawal serve as directors at the Company.
- CIN/LLPIN
U85110CT2001PTC014917
- Company No.
014917
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 Dec 2001
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chhattisgarh
Industry
Company Details
- Location
Raipur, Chattisgarh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Agrawal Institute Of Medical Sciences?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Simmi Agrawal  | Director | 26-Dec-2001 | Current |
| Sajan Agrawal | Director | 26-Dec-2001 | Current |
| Siddharth Agrawal | Director | 10-Jul-2021 | Current |
Financial Performance of Agrawal Institute Of Medical Sciences.
Agrawal Institute Of Medical Sciences Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 75.58% increase. The company also saw a substantial improvement in profitability, with a 190.18% increase in profit. The company's net worth moved up by a moderate rise of 8.91%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Agrawal Institute Of Medical Sciences?
In 2020, Agrawal Institute Of Medical Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Indian Overseas Bank Creation Date: 22 Jul 2021 | ₹2.00 Cr | Open |
Indian Overseas Bank Creation Date: 01 Aug 2005 | ₹2.55 Cr | Satisfied |
How Many Employees Work at Agrawal Institute Of Medical Sciences?
Unlock and access historical data on people associated with Agrawal Institute Of Medical Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Agrawal Institute Of Medical Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Agrawal Institute Of Medical Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
